One day versus two days of hepatic arterial infusion with oxaliplatin and fluorouracil for patients with unresectable hepatocellular carcinoma
ZhiCheng Lai(Sun Yat-sen University), Ming Shi(Yanshan University), Li Xu(Jiangxi University of Traditional Chinese Medicine), YeXing Huang(Sun Yat-sen University), Dongsheng Wen(Technical University of Munich), Xuanjia Lin(Sun Yat-sen University), Wei Wei(Zhujiang Hospital), Minshan Chen(Sun Yat-sen University), QiJiong Li(Sun Yat-sen University), Minke He(Sun Yat-sen University), Anna Kan(Sun Yat-sen University)
Cited by 35
Related Papers
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
|Liver International|2015|1.3k
Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial
|Clinical Cancer Research|2020|576